Document Detail


Anticoagulant-associated intracerebral hemorrhage.
MedLine Citation:
PMID:  21207349     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
The incidence of anticoagulant-associated intracerebral hemorrhage (AAICH) quintupled during the 1990 s, probably due to increased warfarin use for the treatment of atrial fibrillation. Anticoagulant-associated intracerebral hemorrhage now accounts for nearly 20% of all intracranial hemorrhage (ICH). Among patients using warfarin for atrial fibrillation, the annual risk of ICH in trials is 0.3 to 1.0%. Predictors of potential anticoagulant-associated hemorrhage are increasing age, prior ischemic stroke, hypertension, leukoaraiosis, the early period of warfarin use, higher intensity anticoagulation, and antiplatelet use in addition to anticoagulation. Compared with other intracranial hemorrhage patients, anticoagulated patients have a greater risk of hematoma expansion, subsequent clinical deterioration and death, necessitating vigorous reversal of their coagulopathy. Recommended methods of warfarin reversal are administration of intravenous vitamin K and either prothrombin complex concentrates or fresh frozen plasma. Reversal of unfractionated heparin is accomplished with intravenous protamine sulfate. Surgical treatment of intracranial hemorrhage may be life saving in select cases, but has not reduced morbidity or mortality in large randomized trials.
Authors:
Matthew L Flaherty
Related Documents :
19427429 - Ability of retinopathy to predict cardiovascular disease in patients with type 2 diabet...
22532169 - Accuracy of subjective and objective handwriting assessment for differentiating parkins...
22437899 - Suggested immobilization test for diagnosis of restless legs syndrome in parkinson's di...
16336059 - Efforts to improve subsequent treatment of cardiovascular risk factors in older patient...
17611249 - Predictors of cardiovascular events in patients with end-stage renal disease: an analys...
19850559 - Pregnancy-associated plasma protein-a is an independent short-time predictor of mortali...
8895149 - Anti-pm/scl autoantibodies in patients without clinical polymyositis or scleroderma.
23730959 - Elevated serum ige in recurrent aphthous stomatitis and associations with disease chara...
18458119 - Venous thromboembolic events and erythropoiesis-stimulating agents: an update.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2011-01-04
Journal Detail:
Title:  Seminars in neurology     Volume:  30     ISSN:  1098-9021     ISO Abbreviation:  Semin Neurol     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2011-01-05     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8111343     Medline TA:  Semin Neurol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  565-72     Citation Subset:  IM    
Copyright Information:
© Thieme Medical Publishers.
Affiliation:
Department of Neurology, University of Cincinnati Academic Health Center, Cincinnati, Ohio 45267-0525, USA. matthew.flaherty@uc.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Grant Support
ID/Acronym/Agency:
R01 NS036695/NS/NINDS NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Spontaneous intracerebral hemorrhage.
Next Document:  Home Treatment: Systematic Review and Implementation in Germany.